A role for FOXO1 in BCR-ABL1-independent tyrosine kinase inhibitor resistance in chronic myeloid leukemia
about
Mechanisms of Resistance to ABL Kinase Inhibition in Chronic Myeloid Leukemia and the Development of Next Generation ABL Kinase Inhibitors.Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia.Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy.The impact of Mir-9 regulation in normal and malignant hematopoiesis.A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types.
P2860
A role for FOXO1 in BCR-ABL1-independent tyrosine kinase inhibitor resistance in chronic myeloid leukemia
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A role for FOXO1 in BCR-ABL1-i ...... ce in chronic myeloid leukemia
@en
A role for FOXO1 in BCR-ABL1-i ...... e in chronic myeloid leukemia.
@nl
type
label
A role for FOXO1 in BCR-ABL1-i ...... ce in chronic myeloid leukemia
@en
A role for FOXO1 in BCR-ABL1-i ...... e in chronic myeloid leukemia.
@nl
prefLabel
A role for FOXO1 in BCR-ABL1-i ...... ce in chronic myeloid leukemia
@en
A role for FOXO1 in BCR-ABL1-i ...... e in chronic myeloid leukemia.
@nl
P2093
P2860
P50
P356
P1433
P1476
A role for FOXO1 in BCR-ABL1-i ...... ce in chronic myeloid leukemia
@en
P2093
M W Deininger
P2860
P2888
P304
P356
10.1038/LEU.2016.51
P577
2016-03-08T00:00:00Z